NewAmsterdam Pharma N.V.

NASDAQ: NAMS · Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
24.69
-1.48%
After-hours: Aug 15, 2025, 06:42 PM EDT

NewAmsterdam Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-241.6M -176.94M -78.05M -28.6M
Depreciation & Amortization
113K 49K 72K 14K
Stock-Based Compensation
33.62M 24.57M 4.12M 1.24M
Other Working Capital
-19.73M 796K 11.46M -16.97K
Other Non-Cash Items
81.98M 5.23M 70.57M -7K
Deferred Income Tax
n/a n/a n/a -1.44M
Change in Working Capital
-32.67M 5.87M 11.46M 3.82M
Operating Cash Flow
-158.56M -141.22M 7.97M -25.16M
Capital Expenditures
-672K -24K -13K -20K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-62.18M n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 728K n/a
Investing Cash Flow
-62.85M -24K 715K -20K
Debt Repayment
n/a n/a 747K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 8.91M -5.79M -15.71M
Financial Cash Flow
659.51M 8.91M 375.18M 68.99M
Net Cash Flow
431.29M -127.28M 385.43M 45.23M
Free Cash Flow
-159.24M -141.24M 7.96M -25.18M